Glycaemic control and hypoglycaemia risk with insulin glargine 300 U/mL and insulin degludec 100 U/mL in older participants in the BRIGHT trial

Bolli, G. B., Cheng, A., Charbonnel, B., Aroda, V. R., Westerbacka, J., Bosnyak, Z., … Rosenstock, J. (2021). Glycaemic control and hypoglycaemia risk with insulin glargine 300 U/mL and insulin degludec 100 U/mL in older participants in the BRIGHT trial. Diabetes, Obesity and Metabolism, 23(7), 1588–1593. https://doi.org/10.1111/dom.14372